MedTrace Logo

An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)

NCT01357135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3453

Last updated 2017-06-05

Study results available
· View outcomes & findings →

Summary

This is an observational study to compare the effectiveness of dual therapy of Type II diabetes mellitus with metformin + sitagliptin versus metformin + a sulfonylurea in routine clinical practice in France.

Conditions

Interventions

DRUG

Metformin

DRUG

Sitagliptin

DRUG

Sulfonylurea

DRUG

Antihyperglycemic Medication

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-15
Primary Completion
2013-08-31
Completion
2013-08-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01357135 on ClinicalTrials.gov